Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. 1998

P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
Fundacion Jimenez Diaz, Madrid, Spain.

Previous studies have shown that the A to G transition occurring at position -75 bp upstream of the transcriptional start site in the human apolipoprotein A-I gene may affect plasma high density lipoprotein cholesterol (HDL-C) levels and low density lipoprotein cholesterol (LDL-C) response to changes in amount of dietary fat. We have examined the response to dietary fat saturation as a function of this mutation in 50 men and women. Subjects were first fed a saturated (SAT) fat diet (35% fat, 17% SAT) for 28 days, followed by a diet rich in monounsaturated fatty (MUFA) acids (35% fat, 22% MUFA) for 35 days and a diet rich in polyunsaturated (PUFA) fat (35% fat, 13% PUFA) for 35 days. All meals were prepared and consumed at the study sites. Lipoproteins were measured at the end of each diet period. The allele frequency for the A allele was 0.13. Subjects carrying the A allele had higher plasma cholesterol, LDL-C and triglyceride levels than those homozygotes for the G allele. As compared to the SAT diet, a PUFA diet induced significantly greater plasma total (P = 0.003) and LDL-C decreases (P = 0.001) in G/A women (-1.62 and -1.32 mmol/l, respectively) than in G/G subjects (-0.87 and -0.74 mmol/l for plasma and LDL-C, respectively). Multiple regression analysis demonstrated that in women, the variability in LDL-C response from a diet rich in SAT fat to a diet rich in PUFA was primarily due to LDL-C levels (during the SAT phase), accounting for 55.1% of the variance, waist to hip ratio (W/H; 11.4%) and the G/A polymorphism (10%). Whereas in men the major determinant of this response was smoking (21.4%). In conclusion, the G/A polymorphism appears to have a small but significant effect on plasma LDL-C responsiveness to changes in dietary fat saturation specially in women.

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids
D005231 Fatty Acids, Unsaturated FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds. Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids

Related Publications

P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
May 1994, Lancet (London, England),
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
May 1993, Metabolism: clinical and experimental,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
July 1997, The American journal of clinical nutrition,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
January 1992, Journal of lipid research,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
October 1997, Journal of lipid research,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
May 1993, Clinical genetics,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
September 1999, Journal of lipid research,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
November 1994, The Journal of nutrition,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
May 1996, Biochemical Society transactions,
P Mata, and J Lopez-Miranda, and M Pocovi, and R Alonso, and C Lahoz, and C Marin, and C Garces, and A Cenarro, and F Perez-Jimenez, and M de Oya, and J M Ordovas
August 2005, Metabolism: clinical and experimental,
Copied contents to your clipboard!